INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Operating expenses:        
Research and development, net $ 790 $ 1,503 $ 1,927 $ 4,123
General and administrative 848 1,068 2,506 3,016
Operating loss (1,638) (2,571) (4,433) (7,139)
Financial (income) expenses, net (32) 32 (75) (35)
Net loss $ (1,606) $ (2,603) $ (4,358) $ (7,104)
Basic and diluted net profit (loss) per share (in dollars per share) $ (0.09) $ (0.14) $ (0.23) $ (0.39)
Weighted average number of shares outstanding used in computing basic and diluted net loss per share (in shares) 18,656,615 18,480,957 18,654,826 18,354,580